WELCOME!
We hereby cordially invite you to the 5th Jung Symposium "Excellence in Human Medicine 2025", on May 16, 2025 in the Ian K. Karan auditorium of the University Medical Center Hamburg-Eppendorf.
How can neurodegenerative diseases be targeted effectively? Which new active substances could shape the next generation of cancer medications? And how can the immune system be activated to effectively destroy tumours? These pressing medical questions will be the focus of the 5th Jung Symposium “Excellence in Human Medicine 2025”, taking place on May 16 in Hamburg and available online via livestream. The event is organized by the Hamburg-based, independent Jung Foundation for Science and Research, which has been honouring top-level research with substantial awards since 1967. At this year’s symposium, molecular biologist Professor Elena Conti, PhD, microbiologist Professor Dr Jörn Piel, cancer researcher Dr med. Benjamin Ruf, and immuno-oncologist and Professor Emeritus of the Université Paris Cité, Professor Wolf-Herman Fridman, MD, PhD, will present pioneering findings that open new avenues in the treatment of serious diseases. Following their presentations, these leading researchers will be available to answer questions from the audience.
Come and join us in presence in the Ian K. Karan auditorium, Campus Lehre, N55, University Medical Center Hamburg-Eppendorf or watch the presentations from 13:00 via our livestream. If you would like to watch the events digitally via the livestream, please register using the button below on the left. You will then receive the access link from us a few days before the event. If you are interested in participating in the Jung-Symposium in presence in the auditorium, please register using the button below on the right.
PROGRAMME MAY 16, 2025
| 12:00 | Admission |
| 13:00 | Professor Dr Blanche Schwappach-Pignataro, Jung-Stiftung and University Medical Centre Hamburg-Eppendorf
Welcome and opening |
| 13:05 | Dr med. Benjamin Ruf (34), Research Group Leader at the Malignome, Metabolome, and Microbiome Research Center at the Faculty of Medicine at the Eberhard Karls University of Tübingen, physician in training at the Department of Internal Medicine I at University Hospital of Tübingen and member of Germany's only oncology cluster of excellence, the “iFIT”
“Personalized Immunotherapy: Developing the Best Cancer Treatment for Every Patient” |
| 13:40 | Professor Wolf-Herman Fridman, MD, PhD (79), Professor Emeritus of Immunology at the Cordeliers Research Centre of the Université Paris Cité “From Immune Response to Cure: How Immunotherapy is Transforming the Lives of Cancer Patients” |
| 14:20 | Coffee Break |
| 14:40 | Professor Elena Conti, PhD (58), Director at the Max Planck Institute of Biochemistry in Munich
“The RNA Exosome Complex: Molecular Mechanisms of RNA Degradation in Health and Disease” |
| 15:20 | Professor Dr Jörn Piel (58), microbiologist and head of the Bacterial Natural Products research group at the Institute of Microbiology at ETH Zurich
“Nature’s Hidden Pharmacy: New Drugs for Cancer and Antibiotic Research” |
LECTURERS 2025
Dr med. Benjamin Ruf
Research Group Leader at the Malignome, Metabolome, and Microbiome Research Center at the Faculty of Medicine at the University of Tübingen, physician in training at the Department of Internal Medicine I at University Hospital of Tübingen and member of Germany's only oncology cluster of excellence, the “iFIT”
Professor Wolf-Herman Fridman, MD, PhD
Professor Emeritus of Immunology at the Cordeliers Research Centre of the Université Paris Cité
Professor Elena Conti, PhD
Director at the Max Planck Institute of Biochemistry in Martinsried near Munich
Professor Dr Jörn Piel
Microbiologist and head of the Bacterial Natural Products research group at the Institute of Microbiology at ETH Zurich
HOSTS 2025
Prof. Dr Blanche Schwappach-Pignataro
Member of the Board of Trustees and the Scientific Advisory Board
Jochen Spethmann
Chairman of the Board of Trustees
Verena Strasoldo
Management